TinnitusFree has funded the purchase of a NeurOptics® NPi®-300 pupillometer for the University of Otago. This high-quality pupillometer is a portable, automated measuring device that accurately and objectively measures patients' pupil size, symmetry, and light response. The pupillometer is used in clinical studies to measure the effect of neuromodulation on tinnitus patiënten.
The TinnitusFree Foundation has announced funding for a pioneering international research project aimed at identifying the world's first objective diagnostic marker for tinnitus - a major step toward transforming how this common yet often misunderstood condition is diagnosed and treated. The research aims to establish a measurable brain-based biomarker for tinnitus, a breakthrough comparable to how blood pressure readings revolutionized the diagnosis of hypertension. The study, led by Professor Dirk de Ridder, will analyze brainwave data (EEG) to identify a unique "brain signature" associated with tinnitus. Finding an objective diagnostic marker would mark a major breakthrough for both tinnitus research and clinical practice. It would establish the foundation for evidence-based diagnoses, standardized outcome measures, and faster, data-driven development of effective therapies, bringing hope to millions affected by tinnitus. Read the full press release here:
We are continuing our partnership with Harman International (with the JBL brand) into 2025, to facilitate the search for a cure for tinnitus and to increase tinnitus awareness. To celebrate this, we give away a pair of JBL Tour One M3 Headphones. The winner will be chosen via a random web winner picker. The JBL Tour One M3 Headphones are consistently rated as one of the best on the market. Read the press release here:
Traditional evidence-based approaches have so far failed to develop any (FDA or CE approved) treatments for tinnitus, after many years of tinnitus research. It is time for a new approach: War On Tinnitus. This concept of war approach has been proven highly successful in fighting AIDS. It is a highly innovative way to find a solution for tinnitus in a short time frame, i.e., 3 to 5 years. To reduce and ideally abolish the sound - in contrast to most tinnitus studies that attempt to reduce the suffering associated with the tinnitus.